πŸ‡ΊπŸ‡Έ FDA
Patent

US 7205305

Inhibitors of p38

granted A61PA61P1/00A61P1/04

Quick answer

US patent 7205305 (Inhibitors of p38) held by Vertex Pharmaceuticals Incorporated expires Mon Apr 12 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Apr 17 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 12 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61P, A61P1/00, A61P1/04, A61P1/18, A61P11/00